Hofseth BioCare ASA (OSL:HBC)
Norway · Delayed Price · Currency is NOK 1.455
+0.005 (0.34%)
Jul 15, 2026, 3:29 PM CET
Hofseth BioCare ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -138.33 | -134.88 | -125.3 | -106.68 | -137.39 | -126.46 |
Depreciation & Amortization | 32.35 | 32.87 | 32.79 | 29.87 | 24.41 | 25.72 |
Other Amortization | 7.86 | 6.45 | 6.99 | 6.54 | 5.81 | 3.63 |
Loss (Gain) From Sale of Assets | - | - | -8.12 | -23.49 | - | - |
Asset Writedown & Restructuring Costs | 0.09 | 0.09 | - | - | 0.19 | - |
Loss (Gain) on Equity Investments | 50.56 | 50.35 | 151.48 | 2.54 | -0.2 | -0.03 |
Other Operating Activities | 18.22 | 20.02 | 14.06 | 9.49 | 9.95 | 9.39 |
Change in Accounts Receivable | 2.17 | -2.67 | -4 | -0.78 | -3.98 | 4.18 |
Change in Inventory | -5.68 | -3.91 | 26.63 | 33.98 | -25.71 | -17.51 |
Change in Accounts Payable | 6.04 | 0.99 | 38.47 | -90.59 | 70.36 | 39.21 |
Change in Other Net Operating Assets | -0.66 | 2.88 | -144.4 | 141.87 | 11.4 | 0.1 |
Operating Cash Flow | -27.38 | -27.81 | -11.4 | 2.76 | -45.17 | -61.78 |
Capital Expenditures | -29.38 | -19.73 | -2.44 | -8.19 | -4.02 | -22.92 |
Sale (Purchase) of Intangibles | -0.4 | -0.73 | -1.63 | -5.87 | -13.76 | -14.83 |
Investment in Securities | - | - | - | -1.62 | - | -0.19 |
Other Investing Activities | - | - | -0 | 0.69 | - | - |
Investing Cash Flow | -29.77 | -20.47 | -4.07 | -14.99 | -17.78 | -37.94 |
Short-Term Debt Issued | - | 8.78 | 19.4 | 28.35 | - | - |
Long-Term Debt Issued | - | 115.82 | 25.1 | - | - | 1.09 |
Total Debt Issued | 67.97 | 124.6 | 44.5 | 28.35 | - | 1.09 |
Long-Term Debt Repaid | - | -14.04 | -12.98 | -14.18 | -15.05 | -14.89 |
Net Debt Issued (Repaid) | 53.37 | 110.56 | 31.52 | 14.17 | -15.05 | -13.8 |
Issuance of Common Stock | - | - | - | - | 70.78 | - |
Other Financing Activities | -20.51 | -19.06 | -14.36 | -10.48 | -10.28 | -9.39 |
Financing Cash Flow | 32.86 | 91.5 | 17.16 | 3.69 | 45.45 | -23.2 |
Foreign Exchange Rate Adjustments | 1.46 | -1.76 | - | - | - | - |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | 0 |
Net Cash Flow | -22.83 | 41.47 | 1.69 | -8.54 | -17.49 | -122.91 |
Free Cash Flow | -56.76 | -47.54 | -13.84 | -5.43 | -49.19 | -84.7 |
Free Cash Flow Margin | -23.17% | -18.55% | -5.21% | -2.49% | -40.84% | -96.67% |
Free Cash Flow Per Share | -0.14 | -0.12 | -0.03 | -0.01 | -0.13 | -0.24 |
Cash Interest Paid | 21.57 | 19.91 | 14.86 | 9.49 | 9.95 | 9.39 |
Levered Free Cash Flow | -86.19 | -71.16 | 21.85 | -100.88 | -72.21 | -65.15 |
Unlevered Free Cash Flow | -69.97 | -56.89 | 31.66 | -96.16 | -65.99 | -59.28 |
Change in Working Capital | 1.87 | -2.71 | -83.31 | 84.49 | 52.06 | 25.97 |